These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9777115)

  • 1. Central nervous system relapse in acute promyelocytic leukaemia treated with all-trans retinoic acid.
    Seldon M; Enno A
    Aust N Z J Med; 1998 Aug; 28(4):462. PubMed ID: 9777115
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid.
    Degos L; Chomienne C; Daniel MT; Berger R; Dombret H; Fenaux P; Castaigne S
    Lancet; 1990 Dec; 336(8728):1440-1. PubMed ID: 1978887
    [No Abstract]   [Full Text] [Related]  

  • 3. Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia.
    Castagnola C; Elena C; Merli M
    Haematologica; 2008 Feb; 93(2):e28. PubMed ID: 18245644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated central nervous system relapse of acute promyelocytic leukemia with altered morphology in an asymptomatic patient.
    Sardana R; Balakrishna JP
    Blood Cells Mol Dis; 2021 Dec; 92():102616. PubMed ID: 34634584
    [No Abstract]   [Full Text] [Related]  

  • 5. Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid.
    Evans G; Grimwade D; Prentice HG; Simpson N
    Br J Haematol; 1997 Aug; 98(2):437-9. PubMed ID: 9266945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term seventh molecular remission in acute promyelocytic leukaemia.
    Cicconi L; Romano A; Ramadan SM; Divona M; Petti MC; Lo-Coco F
    Ann Hematol; 2011 Nov; 90(11):1369-70. PubMed ID: 21336626
    [No Abstract]   [Full Text] [Related]  

  • 7. 2. All-trans retinoic acid in the treatment of acute promyelocytic leukemia.
    Asou N
    Intern Med; 2007; 46(2):91-3. PubMed ID: 17220606
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary treatment of acute promyelocytic leukemia using all-trans-retinoic acid].
    Leeksma OC; van Oers MH; van der Schoot CE; Goudsmit R; von dem Borne AE
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):821-5. PubMed ID: 8487886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolated relapse in the central nervous system during cytologic and hematologic remission in a patient with acute promyelocytic leukemia].
    Vivanco-Hidalgo RM; Gimeno E; Gálvez A; Rodríguez-Campello A
    Neurologia; 2010 Apr; 25(3):200-1. PubMed ID: 20492869
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of acute promyelocytic leukemia in children with all-trans-retinoic acid].
    Maschan AA; Klebanova NG; Miakova NV; Tiganova OA; Timakov AM; Samochatova EV
    Gematol Transfuziol; 1996; 41(2):43-5. PubMed ID: 8754162
    [No Abstract]   [Full Text] [Related]  

  • 11. Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission.
    Sakurai M; Watanuki S; Kato J; Hashida R; Yamane Y; Karigane D; Mitsuhashi T; Murata M; Ueno H; Nakazato T; Okamoto S; Mori T
    Intern Med; 2018 Nov; 57(22):3299-3302. PubMed ID: 29984744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia.
    Gallipoli P; Drummond MW
    Eur J Haematol; 2009 Mar; 82(3):242-3. PubMed ID: 19018859
    [No Abstract]   [Full Text] [Related]  

  • 13. [All-trans-retinoic acid in the treatment of acute promyelocytic leukemia].
    Degos L
    Presse Med; 1990 Oct; 19(32):1483-4. PubMed ID: 2146649
    [No Abstract]   [Full Text] [Related]  

  • 14. All-trans-retinoic acid in acute promyelocytic leukemia.
    Sanz MA; Martín G; Díaz-Mediavilla J
    N Engl J Med; 1998 Feb; 338(6):393-4. PubMed ID: 9454087
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous relapse in acute promyelocytic leukaemia following treatment with all-trans retinoic acid.
    Chang SE; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
    Br J Dermatol; 1999 Sep; 141(3):586-7. PubMed ID: 10583084
    [No Abstract]   [Full Text] [Related]  

  • 16. Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto.
    Specchia G; Lo Coco F; Vignetti M; Avvisati G; Fazi P; Albano F; Di Raimondo F; Martino B; Ferrara F; Selleri C; Liso V; Mandelli F
    J Clin Oncol; 2001 Oct; 19(20):4023-8. PubMed ID: 11600603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.
    Burry LD; Seki JT
    Ann Pharmacother; 2002 Dec; 36(12):1900-6. PubMed ID: 12452754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of all-trans retinoic acid in adults and children with acute promyelocytic leukemia.
    Takitani K; Koh M; Inoue A; Kawakami C; Kuno T; Tamai H
    Am J Hematol; 2006 Sep; 81(9):720-1. PubMed ID: 16838336
    [No Abstract]   [Full Text] [Related]  

  • 19. All-trans-retinoic acid in acute promyelocytic leukemia.
    Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
    N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to manage acute promyelocytic leukemia.
    Mi JQ; Li JM; Shen ZX; Chen SJ; Chen Z
    Leukemia; 2012 Aug; 26(8):1743-51. PubMed ID: 22422168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.